Molecular Medicine |
From the Vascular Pathophysiology Unit, School of Medicine, University of Navarra, Pamplona, Spain.
Correspondence to Javier Díez, MD, PhD, Unidad de Fisiopatología Vascular, Facultad de Medicina, C/Irunlarrea s/n, 31080 Pamplona, Spain. E-mail jadimar{at}unav.es
AbstractIn
a previous study, we found that the
p22phox
subunit of the NADH/NADPH oxidase is overexpressed in vascular smooth
muscle cells (VSMCs) from spontaneously hypertensive rats (SHRs) with
enhanced vascular production of superoxide anion
(·O2-).
Thus, we have investigated whether changes in the sequence or activity
of the promoter region of
p22phox
gene are present in SHRs. To carry out this analysis, first of all, we
characterized the rat gene structure and promoter region for the
p22phox
subunit. The
p22phox
gene spans
10 kb and contains 6 exons and 5 introns. Primer
extension analysis indicated the transcriptional start site 100 bp
upstream from the translational start site. The immediate promoter
region of the
p22phox
gene does not contain a TATA box, but there are a CCAC box and putative
recognition sites for nuclear factors, such as SP1,
-interferon, and
nuclear factor-
B. Using reporter-gene transfection analysis, we
found that this promoter was functional in VSMCs. Furthermore, we
observed that
p22phox
promoter activity was significantly higher in VSMCs from SHRs than from
normotensive Wistar-Kyoto rats. In addition, we found that there were 5
polymorphisms in the sequence of
p22phox
promoter between Wistar-Kyoto rats and SHRs and that they were
functional. The results obtained in this study provide a tool to
explore the mechanisms that regulate the expression of
p22phox
gene in rat VSMCs. Furthermore, our findings show that changes in the
sequence of
p22phox
gene promoter and in the degree of activation of VSMCs are responsible
for upregulated expression of
p22phox
in SHRs.
Key Words: NADH/NADPH oxidase gene promoter vascular smooth muscle cells superoxide anion
This article has been cited by other articles:
![]() |
A. Manea, S. A. Manea, A. V. Gafencu, M. Raicu, and M. Simionescu AP-1-Dependent Transcriptional Regulation of NADPH Oxidase in Human Aortic Smooth Muscle Cells: Role of p22phox Subunit Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 878 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fortuno, G. S. Jose, M. U Moreno, J. Diez, and G. Zalba Oxidative stress and vascular remodelling Exp Physiol, July 1, 2005; 90(4): 457 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in Hypertension: What Is the Clinical Significance? Hypertension, September 1, 2004; 44(3): 248 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Jose, M. U. Moreno, S. Olivan, O. Beloqui, A. Fortuno, J. Diez, and G. Zalba Functional Effect of the p22phox -930A/G Polymorphism on p22phox Expression and NADPH Oxidase Activity in Hypertension Hypertension, August 1, 2004; 44(2): 163 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Hodgkinson, B. A. Millward, and A. G. Demaine Association of the p22phox Component of NAD(P)H Oxidase With Susceptibility to Diabetic Nephropathy in Patients With Type 1 Diabetes Diabetes Care, November 1, 2003; 26(11): 3111 - 3115. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Azumi, N. Inoue, Y. Ohashi, M. Terashima, T. Mori, H. Fujita, K. Awano, K. Kobayashi, K. Maeda, K. Hata, et al. Superoxide Generation in Directional Coronary Atherectomy Specimens of Patients With Angina Pectoris: Important Role of NAD(P)H Oxidase Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1838 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zalba, G. S. Jose, M. U. Moreno, M. A. Fortuno, A. Fortuno, F. J. Beaumont, and J. Diez Oxidative Stress in Arterial Hypertension: Role of NAD(P)H Oxidase Hypertension, December 1, 2001; 38(6): 1395 - 1399. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |